2027 MDA Clinical and Scientific Conference

Recognized as the leading international meeting dedicated to neuromuscular diseases, the conference convenes renowned researchers, clinicians, affiliated health care providers, academicians, advocates, industry innovators, and advocacy leaders at a moment when scientific discovery is accelerating across the field. The program will feature plenary sessions, thematic sessions, industry sponsored forums and hundreds of peer-reviewed abstracts highlighting advances in next-generation clinical trial design, biomarker development, therapeutic delivery systems, gene and RNA-targeted therapies, and AI-enabled drug discovery that are reshaping how neuromuscular diseases are understood, treated, and managed, underscoring a central reality driving the field forward: time is muscle. Early bird registration is available through December 31, 2026.

Organizer email: [email protected]